Benefit risk assessment and update on the use of docetaxel in the management of breast cancer

por Alken, Scheryll, Kelly, Catherine M
Publicado 2013

Optimal Choice of Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer: Clinical Insights

por Lucas, Mairi W, Kelly, Catherine M
Publicado 2022

Overview of recent advances in metastatic triple negative breast cancer

por O'Reilly, David, Sendi, Maha Al, Kelly, Catherine M
Publicado 2021

The psychosocial determinants of quality of life in breast cancer survivors: a scoping review

por Culbertson, Michael G., Bennett, Kathleen, Kelly, Catherine M., Sharp, Linda, Cahir, Caitriona
Publicado 2020

Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherence

por Cahir, Caitriona, Bennett, Kathleen, Dombrowski, Stephan U., Kelly, Catherine M., Wells, Mary, Watson, Eila, Sharp, Linda
Publicado 2023

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

por Kelly, Catherine M, Juurlink, David N, Gomes, Tara, Duong-Hua, Minh, Pritchard, Kathleen I, Austin, Peter C, Paszat, Lawrence F
Publicado 2010

Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish cent...

por Prior, Lisa, Featherstone, Hannah, O’Reilly, David, Nugent, Killian, Lim, Marvin, McCaffrey, John, Higgins, Michaela J, Kelly, Catherine M.
Publicado 2021

The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study...

por Donohoe, Fionán, O'Meara, Yvonne, Roberts, Aidin, Comerford, Louise, Kelly, Catherine M., Walshe, Janice M., Peate, Michelle, Hickey, Martha, Brennan, Donal J.
Publicado 2021

Using menopausal hormone therapy after a cancer diagnosis in Ireland

por Donohoe, Fionán, O’Meara, Yvonne, Roberts, Aidin, Comerford, Louise, Kelly, Catherine M., Walshe, Janice M., Lundy, Deirdre, Hickey, Martha, Brennan, Donal J.
Publicado 2022

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer

por O´Leary, Patrick C, Penny, Sarah A, Dolan, Roisin T, Kelly, Catherine M, Madden, Stephen F, Rexhepaj, Elton, Brennan, Donal J, McCann, Amanda H, Pontén, Fredrik, Uhlén, Mathias, Zagozdzon, Radoslaw, Duffy, Michael J, Kell, Malcolm R, Jirström, Karin, Gallagher, William M
Publicado 2013

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

por Bianchini, Giampaolo, Pusztai, Lajos, Karn, Thomas, Iwamoto, Takayuki, Rody, Achim, Kelly, Catherine M, Müller, Volkmar, Schmidt, Marcus, Qi, Yuan, Holtrich, Uwe, Becker, Sven, Santarpia, Libero, Fasolo, Angelica, Del Conte, Gianluca, Zambetti, Milvia, Sotiriou, Christos, Haibe-Kains, Benjamin, Symmans, W Fraser, Gianni, Luca
Publicado 2013

Virtual oncology clinics during the COVID-19 pandemic

por O’Reilly, David, Carroll, Hailey, Lucas, Mairi, Sui, Jane, Al Sendi, Maha, McMahon, David, Darwish, Waseem, McLaughlin, Ronan, Khan, Mohammed Raza, Sullivan, Hazel O, Chew, Sonya, Dennehy, Colum, Kelly, Catherine M., McCaffrey, John, Greally, Megan, Carney, Desmond, Higgins, Michaela J.
Publicado 2021

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial

por Galactionova, Katya, Loibl, Sibylle, Salari, Paola, Marmé, Frederik, Martin, Miguel, Untch, Michael, Bonnefoi, Hervé R., Kim, Sung-Bae, Bear, Harry D., McCarthy, Nicole, Gelmon, Karen A., García-Sáenz, José A., Kelly, Catherine M., Reimer, Toralf, Toi, Masakazu, Rugo, Hope S., Gnant, Michael, Makris, Andreas, Burchardi, Nicole, Schwenkglenks, Matthias
Publicado 2022

Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland

por Kearns, Cathriona, Feighery, Ronan, Mc Caffrey, John, Higgins, Michaela, Smith, Martina, Murphy, Verena, O’Reilly, Seamus, Horgan, Anne M., Walshe, Janice, McDermott, Ray, Morris, Patrick G., Keane, Maccon, Martin, Michael, Murphy, Conleth, Duffy, Karen, Mihai, Alina, Armstrong, John, O’Donnell, Dearbhaile M., Gallagher, William M., Kelly, Ciara M., Kelly, Catherine M.
Publicado 2020

Spatial predictors of immunotherapy response in triple-negative breast cancer

por Wang, Xiao Qian, Danenberg, Esther, Huang, Chiun-Sheng, Egle, Daniel, Callari, Maurizio, Bermejo, Begoña, Dugo, Matteo, Zamagni, Claudio, Thill, Marc, Anton, Anton, Zambelli, Stefania, Russo, Stefania, Ciruelos, Eva Maria, Greil, Richard, Győrffy, Balázs, Semiglazov, Vladimir, Colleoni, Marco, Kelly, Catherine M., Mariani, Gabriella, Del Mastro, Lucia, Biasi, Olivia, Seitz, Robert S., Valagussa, Pinuccia, Viale, Giuseppe, Gianni, Luca, Bianchini, Giampaolo, Ali, H. Raza
Publicado 2023

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER”

por Keegan, Niamh M., Furney, Simon J., Walshe, Janice M., Gullo, Giuseppe, Kennedy, M. John, Smith, Diarmuid, McCaffrey, John, Kelly, Catherine M., Egan, Keith, Kerr, Jennifer, Given, Mark, O’Donovan, Peter, Hernando, Andres, Teiserskiene, Ausra, Parker, Imelda, Kay, Elaine, Farrelly, Angela, Carr, Aoife, Calzaferri, Giulio, McDermott, Ray, Keane, Maccon M., Grogan, Liam, Breathnach, Oscar, Morris, Patrick G., Toomey, Sinead, Hennessy, Bryan T.
Publicado 2021